DK1156806T3 - Farmaceutisk sammensætning indeholdende protonpumpeinhibitor - Google Patents

Farmaceutisk sammensætning indeholdende protonpumpeinhibitor

Info

Publication number
DK1156806T3
DK1156806T3 DK00911862T DK00911862T DK1156806T3 DK 1156806 T3 DK1156806 T3 DK 1156806T3 DK 00911862 T DK00911862 T DK 00911862T DK 00911862 T DK00911862 T DK 00911862T DK 1156806 T3 DK1156806 T3 DK 1156806T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical composition
composition containing
proton pump
pump inhibitor
containing proton
Prior art date
Application number
DK00911862T
Other languages
Danish (da)
English (en)
Inventor
Keith Freehauf
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of DK1156806T3 publication Critical patent/DK1156806T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK00911862T 1999-02-23 2000-02-18 Farmaceutisk sammensætning indeholdende protonpumpeinhibitor DK1156806T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12125399P 1999-02-23 1999-02-23

Publications (1)

Publication Number Publication Date
DK1156806T3 true DK1156806T3 (da) 2004-08-02

Family

ID=22395498

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00911862T DK1156806T3 (da) 1999-02-23 2000-02-18 Farmaceutisk sammensætning indeholdende protonpumpeinhibitor

Country Status (30)

Country Link
US (1) US6316481B1 (cs)
EP (1) EP1156806B1 (cs)
JP (1) JP2002537337A (cs)
KR (1) KR100701448B1 (cs)
CN (1) CN1227009C (cs)
AR (1) AR029615A1 (cs)
AT (1) ATE263562T1 (cs)
AU (1) AU771061B2 (cs)
BG (1) BG65291B1 (cs)
BR (1) BR0008403A (cs)
CA (1) CA2362932C (cs)
CO (1) CO5140102A1 (cs)
CZ (1) CZ301647B6 (cs)
DE (1) DE60009675T2 (cs)
DK (1) DK1156806T3 (cs)
EA (1) EA004683B1 (cs)
ES (1) ES2216870T3 (cs)
HR (1) HRP20010615B1 (cs)
HU (1) HU228181B1 (cs)
IL (1) IL144131A0 (cs)
ME (1) ME00864B (cs)
NO (1) NO328863B1 (cs)
NZ (1) NZ512771A (cs)
PL (1) PL195783B1 (cs)
PT (1) PT1156806E (cs)
RS (1) RS50023B (cs)
SK (1) SK286371B6 (cs)
TW (1) TW587936B (cs)
WO (1) WO2000050038A1 (cs)
ZA (1) ZA200106104B (cs)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6852739B1 (en) 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
ATE473002T1 (de) * 2000-05-30 2010-07-15 Merial Ltd Zusammensetzungen zur vorbeugung von geschwüren in pferden
JP4241041B2 (ja) 2000-12-07 2009-03-18 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 酸分解性活性成分を含有するペースト形の医薬品製造物
AU2002234545A1 (en) 2000-12-07 2002-06-18 Byk Gulden Lomberg Chemische Fabrik G.M.B.H. Pharmaceutical preparation in the form of a suspension comprising an acid-labileactive ingredient
DE10061135C1 (de) * 2000-12-07 2002-11-07 Byk Gulden Lomberg Chem Fab Pharmazeutische Zubereitung in Form einer Paste enthaltend einen säurelabilen Wirkstoff
AU2003254282A1 (en) 2002-08-01 2004-02-23 Nitromed, Inc. Nitrosated proton pump inhibitors, compositions and methods of use
GB2394895A (en) * 2002-11-06 2004-05-12 Cipla Ltd Proton pump inhibitor composition in paste form
WO2005000269A1 (en) * 2003-06-26 2005-01-06 Cipla Limited Pharmaceutical formulations comprising a proton pump inhibitor
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
WO2006026829A1 (en) * 2004-09-09 2006-03-16 Metelli Pty Ltd Stable paste composition of enteric coated acid labile active agent and use thereof
CN101500553B (zh) * 2006-07-25 2012-04-18 维克塔有限公司 联合使用小分子二羧酸的衍生物与ppi用于抑制胃酸分泌的组合物和方法
JP4588791B2 (ja) * 2007-02-16 2010-12-01 あすか製薬株式会社 微粒子油性懸濁液を含む医薬組成物
US20110038933A1 (en) 2008-05-06 2011-02-17 Dexcell Ltd. Stable benzimidazole formulation
AU2010276404A1 (en) 2009-07-20 2012-02-02 Vetegen, Llc A stable pharmaceutical omeprazole formulation for oral administration
US8722636B2 (en) 2011-01-31 2014-05-13 New Market Pharmaceuticals, LLC Animal treatments
US10064849B2 (en) 2012-05-02 2018-09-04 New Market Pharmaceuticals Pharmaceutical compositions for direct systemic introduction
BR112014027352B1 (pt) * 2012-05-02 2022-10-25 New Market Pharmaceuticals Composições farmacêuticas para a introdução sistêmica direta
PL3057571T3 (pl) * 2013-10-18 2019-07-31 Norbrook Laboratories Limited Kompozycje w postaci pasty zawierającej inhibitor pompy protonowej
GB2524351B (en) * 2013-10-18 2016-12-14 Norbrook Lab Ltd Proton Pump Inhibitor Paste Compositions
MX383502B (es) 2015-12-08 2025-03-14 Luoda Pharma Ltd Métodos y composiciones para el tratamiento de úlceras gástricas
US10736855B2 (en) 2016-02-25 2020-08-11 Dexcel Pharma Technologies Ltd. Compositions comprising proton pump inhibitors
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
KR102419769B1 (ko) * 2016-08-11 2022-07-13 아다미스 파마슈티칼스 코포레이션 약물 조성물
EP3720844A4 (en) 2017-12-08 2021-08-11 Adamis Pharmaceuticals Corporation MEDICINAL COMPOSITIONS
ES2723873B1 (es) * 2018-03-01 2020-05-13 Hernan Ma Carmen Batanero Medicamento combinado con omeprazol y vitamina B12
CN112972481A (zh) * 2021-03-18 2021-06-18 华农（肇庆）生物产业技术研究院有限公司 药物组合物及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4255432A (en) 1979-09-06 1981-03-10 Syntex (U.S.A.) Inc. 8-[2-3-Indolyl)ethyl]-1-oxa-3-,8-diazaspiro[4.5]decan-2-ones, pharmaceutical compositions thereof and methods of use thereof
DK130287D0 (da) 1987-03-13 1987-03-13 Benzon As Alfred Oralt praeparat
SE9301489D0 (sv) 1993-04-30 1993-04-30 Ab Astra Veterinary composition
US5708017A (en) * 1995-04-04 1998-01-13 Merck & Co., Inc. Stable, ready-to-use pharmaceutical paste composition containing proton pump inhibitors

Also Published As

Publication number Publication date
DE60009675D1 (de) 2004-05-13
AU771061B2 (en) 2004-03-11
HUP0200325A2 (en) 2002-06-29
IL144131A0 (en) 2002-05-23
NO328863B1 (no) 2010-05-31
NZ512771A (en) 2003-02-28
CZ301647B6 (cs) 2010-05-12
PL195783B1 (pl) 2007-10-31
HUP0200325A3 (en) 2003-05-28
KR100701448B1 (ko) 2007-03-30
CA2362932C (en) 2010-11-30
EP1156806B1 (en) 2004-04-07
CN1227009C (zh) 2005-11-16
EA200100905A1 (ru) 2002-02-28
ME00864B (me) 2008-09-29
CZ20013058A3 (cs) 2001-11-14
PL350729A1 (en) 2003-01-27
DE60009675T2 (de) 2005-03-24
AR029615A1 (es) 2003-07-10
BR0008403A (pt) 2002-01-29
CO5140102A1 (es) 2002-03-22
SK12062001A3 (sk) 2001-12-03
ATE263562T1 (de) 2004-04-15
RS50023B (sr) 2008-09-29
CA2362932A1 (en) 2000-08-31
CN1341022A (zh) 2002-03-20
US6316481B1 (en) 2001-11-13
HU228181B1 (en) 2013-01-28
SK286371B6 (sk) 2008-08-05
ZA200106104B (en) 2002-12-24
NO20014074D0 (no) 2001-08-22
BG105754A (en) 2002-03-29
BG65291B1 (bg) 2007-12-28
WO2000050038A1 (en) 2000-08-31
NO20014074L (no) 2001-08-22
HRP20010615A2 (en) 2002-12-31
HRP20010615B1 (hr) 2011-03-31
EA004683B1 (ru) 2004-06-24
ES2216870T3 (es) 2004-11-01
YU50401A (sh) 2004-05-12
PT1156806E (pt) 2004-07-30
KR20010102297A (ko) 2001-11-15
JP2002537337A (ja) 2002-11-05
EP1156806A1 (en) 2001-11-28
HK1041650A1 (en) 2002-07-19
AU3368700A (en) 2000-09-14
TW587936B (en) 2004-05-21

Similar Documents

Publication Publication Date Title
DE60009675D1 (de) Protonenpumpinhibitoren enthaltende zusammensetzung
NO20015175D0 (no) Farmasöytisk sammensetning
FI991485A0 (fi) Uusi farmaseuttinen koostumus
PT1242087E (pt) Composicoes farmaceuticas
EE200100483A (et) Põletikuvastaste vahenditena kasutatavad ühendid
NO20020275D0 (no) Imidazoimidazoler og -triazoler som anti-inflammatoriske midler
DK1189853T3 (da) Betonformulering
ATE293970T1 (de) Lipasehemmer enthaltende pharmazeutische zusammensetzungen
FI20010683L (fi) Nateglinidiä sisältävä koostumus
IS5046A (is) Lyfjasamsetningar
DE69925989D1 (de) Kompaktpumpe
DE60037666D1 (de) Mehrschichtige flüssige zusammensetzung
FIU20000164U0 (fi) Uusi farmaseuttinen formulaatio
DE60127002D1 (de) Pharmazeutische zusammensetzung
NO20020086L (no) Smaksmaskerte farmasöytiske flytende formuleringer
AT7729U3 (de) Pharmazeutische zusammensetzungen enthaltend amlodipinmaleat
ID29785A (id) Komposisi-komposisi sampo
IL150062A0 (en) Proton pump inhibitors
DE59914882D1 (de) Pumpenaggregat
DE69943245D1 (de) Gaserzeugende zusammensetzung
NO20014926D0 (no) Farmasöytiske forbindelser
PT1239832E (pt) Composicoes farmaceuticas
ATE281076T1 (de) Flüssige herbizidzusammensetzung
PT1227817E (pt) Composicao farmaceutica aquosa contendo ciclesonida
DE60030057D1 (de) Schraubenpumpe